India pharma faces global headwinds; Angel One sees 39% upside in Lincoln Pharma

India’s pharmaceutical industry is facing an outlook: demand and exports remain growth drivers, but global trade disruptions, regulatory hurdles and rising costs are creating pressure on drugmakers. Against this backdrop, Angel One has pick
Read more...